En

DOÇ.DR. ŞERİF ŞENTÜRK İZMİR ULUSLARARASI BİYOTIP VE GENOM ENSTİTÜSÜ GENOM BİLİMLERİ VE MOLEKÜLER BİYOTEKNOLOJİ ANABİLİM DALI

  • Eğitim / Akademik Bilgisi
    Lisans  Boğaziçi Üniversitesi Fen - Edebiyat Fakültesi Moleküler Biyoloji ve Genetik  2003
    Doktora  İ. D. Bilkent Üniversitesi Enstitü Moleküler Biyoloji ve Genetik Dalı  2010
    Yardımcı Doçent  Dokuz Eylül Üniversitesi İzmir Uluslararası Biyotıp ve Genom Enstitüsü  2015
    Doçent  Üniversitelerarası Kurul Başkanlığı Moleküler Biyoloji ve Genetik  2017
  • NO AD YIL
    1  Next-Generation Liver Medicine Using Organoid Models...  2019
    2  Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma...  2018
    3  Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization...  2017
    4  TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functi...  2016
    5  A rapid and tunable method to temporally control Cas9 expression enables the identification of essen...  2015
    6  MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppressio...  2015
    7  p53psi is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like ...  2014
    8  Imetelstat (a telomerase antagonist) exerts off target effects on the cytoskeleton...  2013
    9  Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activa...  2011
    10  Dose- and time-dependent expression patterns of zebrafish orthologs of selected E2F target genes in ...  2011
    11  Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tu...  2010
    12  The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity...  2010
    13  Senescence and immortality in hepatocellular carcinoma...  2009
    14  Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells...  2009
    15  Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells...  2006
  • NO AD TARİH
    1  TGF-beta'ya bağlı kanser hücre sekretomunun regülasyonunda Malt1'ın rolü... 14/11/2019 - 17/11/2019
    2  Hepatoselüler karsinomda AXL'ın rolü... 14/11/2019 - 17/11/2019
    3  Hepatoselüler karsinom hücre hatlarında Malt1 tükenmesinin büyüme baskılayıcı etkilerinin a... 14/11/2019 - 17/11/2019
    4  Hepatoselüler karsinomda TGF-ß yanıtının hücresel mekanizmalarının araştırılması... 14/11/2019 - 17/11/2019
    5  Malign plevral mezotelyoma tümörigenez mekanizmalarının CRISPR-Cas9 tarama ile araştırılması... 14/11/2019 - 17/11/2019
    6  İnvaziv olan ve invaziv olmayan mesane kanseri hücre hatlarını karakterize eden transkripsiyonel... 14/11/2019 - 17/11/2019
    7  Genome-wide CRISPR-Cas9 Screening for Identification of Cancer Essential Genes in Malign Pleural Mes... 27/10/2019 - 31/10/2019
    8  HEPATOSELÜLER KARSİNOMADA YENİ YAKLAŞIM: POTANSİYEL İLAÇ HEDEFİ OLARAK AXL RESEPTÖRÜ... 14/10/2019 - 17/10/2019
    9  Identification of transcriptional regulatory networks characterizing invasive and non-invasive bladd... 03/10/2019 - 05/10/2019
    10  Malt1 Paracaspase Inhibition Reduces Hepatocellular Carcinoma Cell Survival... 18/09/2019 - 22/09/2019
    11  Hepatoselüler Karsinom'da TGF-beta Direncinin Hücresel Mekanizmalarının Araştırılması... 21/02/2019 - 23/02/2019
    12  Malt1 Parakaspazın Hepatoselüler Karsinom Hücre Sağkalımı Üzerindeki Rolünün Araştırılma... 21/02/2019 - 23/02/2019
    13  Kanser Esansiyel Genlerin Tüm Genom CRISPR-Cas9 Taramalarla Araştırılması... 18/10/2018 - 21/10/2018
    14  AXL as a Potential Target in Liver Cancer... 05/09/2018 - 08/09/2018
    15  Systematic Comparison of Constitutive Promoters in Chinese Hamster Ovary Cells... 05/09/2018 - 08/09/2018
    16  Engineering and Functional Validation of Clonal Cell Lines with Stable Cas9 Expression for Genome-Wi... 05/09/2018 - 08/09/2018
    17  The Role of Malt1 Paracaspase in Hepatocellular Carcinoma... 05/09/2018 - 08/09/2018
    18  Investigation of the Cellular Mechanisms of TGF-beta-induced Senescence-Resistance in Hepatocellular... 05/09/2018 - 08/09/2018
    19  The New Frontier of Genome Engineering: The CRISPR-Cas9 System ... 24/05/2018 - 27/05/2018
    20  Genom Mühendisliği ve CRISPR-Cas Devrimi... 10/05/2018 - 13/05/2018
    21  Biomarkers and CRISPR... 10/05/2017 - 12/05/2017
    22  CRISPR-Cas9 İşlevsel Genomik Tarama ve Rekabet Tayini ile Kanser Esansiyel Genlerin Keşfi ve İn ... 10/02/2017 - 12/02/2017
    23  Truncating Alleles in TP53 Produce Separation of Function Mutants That Actively Promote Tumorigenesi... 01/06/2016 - 05/06/2016
    24  In Vitro and In Vivo Characterization Of Cell Survival Genes Using Destabilized Cas9... 04/05/2016 - 07/05/2016
    25  A rapid and tunable method to temporally control Cas9 expression enables the characterization of ess... 24/09/2015 - 27/09/2015
    26  Does Akt inactivation promote metastasis of PTEN mutant cancer?... 12/05/2015 - 16/05/2015
    27  Functional characterization of genomic abnormalities that cooperate with EGFR and K-Ras oncogenic mu... 11/05/2015 - 12/05/2015
    28  Myc drives Pten/p53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression ... 18/04/2015 - 22/04/2015
    29  p53psi is a neomorphic p53 isoform that reprograms cells towards the acquisition of metastatic featu... 14/08/2012 - 18/08/2012
    30  SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL-6 mediated signaling... 14/08/2012 - 18/08/2012
    31  Substrate specifity of receptor tyrosine kinases is critical for selective signaling... 14/08/2012 - 18/08/2012
    32  The Effects of Telomerase Inhibitor GRN163L (Imetelstat) On Cell Cytoskeleton and Cell Cycle... 28/10/2009 - 31/10/2009
    33  Effect of Akt pathway inhibitors in HCC: a novel target for treatment... 03/09/2009 - 06/09/2009
    34  The Effects of Telomerase Inhibitor "GRN163L" on Different Cell Lines... 11/07/2009 - 16/07/2007
    35  Downregulation and the anti-growth effect of Zeb2 in hepatocellular carcinoma... 21/05/2009 - 24/05/2009
    36  TGF-beta induces senescence in epithelial-like hepatocellular carcinoma cells... 21/05/2009 - 24/05/2009
    37  Molecular Mechanisms of TGF-beta-induced senescence in hepatocellular carcinoma... 29/10/2008 - 01/11/2008
    38  TGF-beta induces p53/Rb-independent, but oxidative stress-dependent cellular senescence in hepatocel... 05/10/2007 - 07/10/2007
    39  SMAD interacting protein 1 (SIP-1) acts as a negative regulator of growth in hepatocellular carcinom... 05/10/2007 - 07/10/2007
    40  Senescence induction as a potential therapeutic strategy in hepatocellular carcinoma... 13/09/2007 - 16/09/2007
    41  Induction of senescence as a potential therapeutic strategy in hepatocellular carcinoma... 09/07/2007 - 10/07/2007
    42  Role of SMAD interacting protein 1 in reprogramming of replicative senescence... 24/03/2007 - 26/03/2007
    43  Role of TGF-beta and ROS signaling pathways in hepatocellular senescence... 24/03/2007 - 26/03/2007
    44  Induction of replicative senescence in hepatocellular carcinoma cells... 24/06/2006 - 29/06/2006
    45  Role of TGF-beta signaling in hepatocellular senescence... 22/06/2006 - 24/06/2006
    46  TGF-beta Signaling and Hepatocellular Senescence... 22/06/2006 - 24/06/2006
    47  Characterization of TGF-beta-induced Early Senescence in Hepatocellular Carcinoma Cell Lines... 26/03/2006 - 31/03/2006
  • NO BÖLÜM ADI YIL
    1  Inducible CRISPR-Based Genome Editing for the Characterization of Cancer Genes Genome Editing and Engineering...  2018
  • NO AD TARIH
    1  Hepatoselüler Kanserde Tgf-ß Tarafından İndüklenen Senesans Karşıtı Direnç Mekanizmalarının Tüm Genom Transkriptom Analizi Ile Araştırılması...  6/2018 - /
    2  AXL'in KARACİĞER KANSERİN'DEKİ ROLÜ...  11/2017 - /
  • NO AD YIL
    1  Üstün Başarılı Genç Bilim İnsanı...  2017
    2  Bilim Akademisi Genç Bilim İnsanı...  2019